Snehal Patel's Insider Trades & SAST Disclosures
Snehal Patel's most recent trade in Greenwich LifeSciences Inc was a trade of 2,500 Common Stock done at an average price of $12.5 . Disclosure was reported to the exchange on Jan. 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Snehal Patel.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Greenwich LifeSciences Inc | Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.51 per share. | 10 Jan 2025 | 2,500 | 5,552,502 | - | 12.5 | 31,275 | Common Stock |
| Greenwich LifeSciences Inc | Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.75 per share. | 06 Jan 2025 | 1,800 | 5,550,002 | - | 13.8 | 24,750 | Common Stock |
| Greenwich LifeSciences Inc | Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.31 per share. | 06 Jan 2025 | 1,100 | 5,548,202 | - | 13.3 | 14,641 | Common Stock |
| Greenwich LifeSciences Inc | Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.95 per share. | 03 Jan 2025 | 3,400 | 5,547,102 | - | 13.0 | 44,030 | Common Stock |
| Greenwich LifeSciences Inc | Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.97 per share. | 02 Jan 2025 | 2,000 | 5,543,702 | - | 12.0 | 23,940 | Common Stock |
| Greenwich LifeSciences Inc | Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.36 per share. | 31 Dec 2024 | 2,400 | 5,541,702 | - | 11.4 | 27,264 | Common Stock |
| Greenwich LifeSciences Inc | Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.12 per share. | 30 Dec 2024 | 3,200 | 5,539,302 | - | 11.1 | 35,584 | Common Stock |
| Greenwich LifeSciences Inc | S. Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Dec 2024 | 1,148,723 | 2,222,454 | - | - | Stock Options | |
| Greenwich LifeSciences Inc | S. Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Dec 2024 | 25,008 | 2,247,462 | - | - | Stock Options | |
| Greenwich LifeSciences Inc | Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.63 per share. | 26 Sep 2024 | 1,500 | 5,536,102 | - | 14.6 | 21,945 | Common Stock |
| Greenwich LifeSciences Inc | Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.81 per share. | 06 Aug 2024 | 2,000 | 5,534,602 | - | 13.8 | 27,620 | Common Stock |
| Greenwich LifeSciences Inc | Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.18 per share. | 05 Aug 2024 | 5,500 | 5,532,602 | - | 13.2 | 72,490 | Common Stock |
| Greenwich LifeSciences Inc | Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.89 per share. | 23 Jul 2024 | 1,500 | 5,527,102 | - | 15.9 | 23,835 | Common Stock |
| Greenwich LifeSciences Inc | Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.30 per share. | 13 Jun 2024 | 174,825 | 5,525,602 | - | 14.3 | 2,499,998 | Common Stock |
| Greenwich LifeSciences Inc | Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.08 per share. | 01 Apr 2024 | 3,000 | 5,350,777 | - | 19.1 | 57,240 | Common Stock |
| Greenwich LifeSciences Inc | Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.98 per share. | 22 Mar 2024 | 2,500 | 5,347,777 | - | 20.0 | 49,950 | Common Stock |
| Greenwich LifeSciences Inc | Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.68 per share. | 20 Mar 2024 | 1,500 | 5,345,277 | - | 17.7 | 26,520 | Common Stock |
| Greenwich LifeSciences Inc | Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.49 per share. | 05 Mar 2024 | 3,500 | 5,343,777 | - | 12.5 | 43,715 | Common Stock |
| Greenwich LifeSciences Inc | Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.03 per share. | 04 Mar 2024 | 4,100 | 5,340,277 | - | 13.0 | 53,423 | Common Stock |
| Greenwich LifeSciences Inc | Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.16 per share. | 16 Feb 2024 | 10,800 | 5,336,177 | - | 11.2 | 120,528 | Common Stock |
| Greenwich LifeSciences Inc | S. Patel Snehal | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.07 per share. | 15 Feb 2024 | 12,700 | 5,325,377 | - | 11.1 | 140,589 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.97 per share. | 22 Aug 2023 | 1,000 | 5,291,177 | - | 10.0 | 9,970 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.55 per share. | 04 Aug 2023 | 2,000 | 5,290,177 | - | 10.6 | 21,100 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.20 per share. | 21 Jul 2023 | 1,000 | 5,288,177 | - | 9.2 | 9,200 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.69 per share. | 17 May 2023 | 1,000 | 5,287,177 | - | 11.7 | 11,690 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.10 per share. | 19 Apr 2023 | 7,000 | 5,286,177 | - | 11.1 | 77,700 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.12 per share. | 18 Apr 2023 | 2,000 | 5,279,177 | - | 11.1 | 22,240 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.42 per share. | 11 Apr 2023 | 5,000 | 5,271,177 | - | 12.4 | 62,100 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.12 per share. | 10 Mar 2023 | 1,000 | 2,737,486 | - | 12.1 | 12,120 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.53 per share. | 17 Feb 2023 | 600 | 2,736,486 | - | 16.5 | 9,918 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.68 per share. | 10 Feb 2023 | 1,000 | 2,735,886 | - | 18.7 | 18,680 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.35 per share. | 27 Jan 2023 | 2,000 | 2,734,886 | - | 19.4 | 38,700 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.37 per share. | 20 Jan 2023 | 1,500 | 2,732,886 | - | 17.4 | 26,055 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.18 per share. | 06 Jan 2023 | 1,500 | 2,731,386 | - | 15.2 | 22,770 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.19 per share. | 29 Dec 2022 | 4,000 | 2,729,886 | - | 15.2 | 60,760 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.01 per share. | 16 Dec 2022 | 1,000 | 2,725,886 | - | 13.0 | 13,010 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.11 per share. | 09 Dec 2022 | 2,000 | 2,724,886 | - | 13.1 | 26,220 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.84 per share. | 02 Dec 2022 | 1,000 | 2,722,886 | - | 13.8 | 13,840 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.79 per share. | 02 Nov 2022 | 2,000 | 2,721,886 | - | 8.8 | 17,580 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.75 per share. | 14 Oct 2022 | 3,000 | 2,719,886 | - | 9.8 | 29,250 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.72 per share. | 07 Oct 2022 | 2,000 | 2,716,886 | - | 9.7 | 19,440 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.46 per share. | 30 Sep 2022 | 1,000 | 2,714,886 | - | 9.5 | 9,460 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.23 per share. | 29 Sep 2022 | 1,000 | 2,713,886 | - | 9.2 | 9,230 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.13 per share. | 24 Jun 2022 | 22,535 | 2,706,421 | - | 9.1 | 205,745 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.13 per share. | 24 Jun 2022 | 6,465 | 2,712,886 | - | 9.1 | 59,025 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,048,723 | 1,048,723 | - | - | Stock Options | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 25,008 | 1,073,731 | - | - | Stock Options | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.13 per share. | 16 Jun 2022 | 8,000 | 2,683,886 | - | 7.1 | 57,040 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.91 per share. | 14 Jun 2022 | 12,000 | 2,675,886 | - | 7.9 | 94,920 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.33 per share. | 10 Jun 2022 | 12,000 | 2,663,886 | - | 8.3 | 99,960 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.90 per share. | 09 Jun 2022 | 4,500 | 1,243,453 | - | 10.9 | 49,050 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.55 per share. | 07 Jun 2022 | 6,000 | 1,238,953 | - | 8.6 | 51,300 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.35 per share. | 03 Jun 2022 | 9,250 | 1,232,953 | - | 8.4 | 77,238 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.38 per share. | 02 Jun 2022 | 6,774 | 1,223,703 | - | 7.4 | 49,992 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.09 per share. | 21 Apr 2022 | 6,000 | 1,216,929 | - | 16.1 | 96,540 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.74 per share. | 19 Apr 2022 | 6,000 | 1,210,929 | - | 16.7 | 100,440 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.80 per share. | 11 Feb 2022 | 5,500 | 1,204,929 | - | 19.8 | 108,900 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.59 per share. | 04 Feb 2022 | 5,000 | 1,199,429 | - | 19.6 | 97,950 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.99 per share. | 13 Jan 2022 | 1,000 | 1,194,429 | - | 20.0 | 19,990 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 23.82 per share. | 03 Jan 2022 | 2,050 | 1,193,429 | - | 23.8 | 48,831 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 27.17 per share. | 14 Dec 2021 | 1,840 | 1,191,379 | - | 27.2 | 49,992 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Purchase of securities on an exchange or from another person at price $ 36.98 per share. | 13 Apr 2021 | 2,700 | 1,189,539 | - | 37.0 | 99,853 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Purchase of securities on an exchange or from another person at price $ 5.40 per share. | 19 Nov 2020 | 2,000 | 1,186,839 | - | 5.4 | 10,795 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 1,144,529 | 1,321,327 | - | - | Common Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 1,144,529 | 0 | - | - | Series A Preferred Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 176,448 | 1,040,131 | - | - | Common Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 176,448 | 0 | - | - | Series A Preferred Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Purchase of securities on an exchange or from another person at price $ 5.75 per share. | 29 Sep 2020 | 114,347 | 863,683 | - | 5.7 | 657,495 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 103,911 | 1,168,172 | - | - | Common Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 89,510 | 0 | - | - | Series D Preferred Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 76,780 | 76,780 | - | - | Common Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 76,780 | 0 | - | - | Series B Preferred Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 52,620 | 129,400 | - | - | Common Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 50,001 | 1,408,033 | - | - | Common Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 45,328 | 0 | - | - | Series D Preferred Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 43,072 | 0 | - | - | Series D Preferred Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 33,708 | 1,358,032 | - | - | Common Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 33,708 | 0 | - | - | Series C Preferred Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Purchase of securities on an exchange or from another person at price $ 4.60 per share. | 29 Sep 2020 | 16,667 | 1,184,839 | - | 4.6 | 76,710 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Other type of transaction at price $ 0.00 per share. | 29 Sep 2020 | 14,401 | 14,401 | - | - | Series D Preferred Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 14,401 | 0 | - | - | Series D Preferred Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 13,736 | 1,053,867 | - | - | Common Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 13,736 | 0 | - | - | Series B Preferred Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 10,394 | 1,064,261 | - | - | Common Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 10,394 | 0 | - | - | Series C Preferred Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Other type of transaction at price $ 0.00 per share. | 29 Sep 2020 | 7,292 | 7,292 | - | - | Series D Preferred Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 7,292 | 0 | - | - | Series D Preferred Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Other type of transaction at price $ 0.00 per share. | 29 Sep 2020 | 6,929 | 6,929 | - | - | Series D Preferred Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 6,929 | 0 | - | - | Series D Preferred Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 2,997 | 1,324,324 | - | - | Common Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 2,997 | 0 | - | - | Series B Preferred Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges